首页> 外文OA文献 >A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment

【2h】

A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment

机译：将伊克西克替氏菌采血与富马酸酯和甲氨蝶呤的疗效和安全性与系统治疗中适度至严重的斑块牛皮癣患者患者的疗效和安全性比较了IXekizumab对富马酸酯和甲氨蝶呤的疗效和安全性的24周的多期式

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
K. Reich; M. Augustin; D. Thaçi; A. Pinter; A. Leutz; C. Henneges; E. Schneider; A. Schacht; M. Dossenbach; U. Mrowietz;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment [J] . Reich K., Augustin M., Tha?i D., British Journal of Dermatology . 2020,第4期

机译：在适度至严重的斑块牛皮癣对系统治疗中，将Ixekizumab与富马酸酯和甲氨蝶呤的疗效和安全性比较了24周的多期式，随机的开放标签，并行组研究比较了Ixekizumab与富马酸酯和甲氨蝶呤的疗效和安全性
2. Fumaric acid esters in combination with a 6‐week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate‐to‐severe plaque psoriasis: a randomized prospective clinical study [J] . Tzaneva S., Geroldinger A., Trattner H., British Journal of Dermatology . 2018,第3期

机译：富马酸酯与6周窄带紫外线课程组合提供了加速响应与中度至重度斑块牛皮癣患者的富马酸酯单疗法相比：随机性前瞻性临床研究
3. Fumaric acid esters in combination with a 6‐week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate‐to‐severe plaque psoriasis: a randomized prospective clinical study [J] . Tzaneva S., Geroldinger A., Trattner H., British Journal of Dermatology . 2018,第3期

机译：富马酸酯与6周窄带紫外线课程组合提供了加速响应与中度至重度斑块牛皮癣患者的富马酸酯单疗法相比：随机性前瞻性临床研究
4. Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week open‐label phase 3 study (UNCOVER‐J) [O] . Hidehisa Saeki, Hidemi Nakagawa, Ko Nakajo, -1

机译：ixekizumab治疗对中度至重度斑块状牛皮癣红皮病性牛皮癣和广义脓疱性牛皮癣的日本患者的疗效和安全性：一项为期52周的开放标签的3期研究（UNCOVER-J）
5. Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment [O] . A. Leutz, A. Pinter, D. Thaçi, 2020

机译：从富马酸酯或甲氨蝶呤在中度至重度斑块的牛皮癣患者中切换到全身治疗后的富氨酸蛋白或甲氨蝶呤后的疗效和安全性

A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment

著录项

相似文献

相关主题

期刊订阅